Patents by Inventor Kenneth Frederick Cowan
Kenneth Frederick Cowan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240050759Abstract: In embodiments, an external defibrillator has an electrical circuit with a special output stage for the high-voltage defibrillation pulse. The output stage includes switches that can turn on for delivering the pulse, and off during all other times. The output stage also includes a diverting resistance to divert electrical current that could leak into the patient while a capacitor is being charged. An optional detector may notify if a component is malfunctioning. An advantage can be that an external defibrillator may be created according to embodiments that uses, in its output stage, semiconductor switches instead of relays. As semiconductor switches weigh less and occupy less volume than relays, an external defibrillator according to embodiments may have less weight and volume. Especially in wearable defibrillator applications, less weight means less effort to carry and less volume means easier concealment under clothing.Type: ApplicationFiled: October 24, 2023Publication date: February 15, 2024Applicant: West Affum Holdings DACInventors: Kenneth Frederick Cowan, Joseph Sullivan, Brian J. Bennett
-
Patent number: 11794024Abstract: In embodiments, an external defibrillator has an electrical circuit with a special output stage for the high-voltage defibrillation pulse. The output stage includes switches that can turn on for delivering the pulse, and off during all other times. The output stage also includes a diverting resistance to divert electrical current that could leak into the patient while a capacitor is being charged. An optional detector may notify if a component is malfunctioning. An advantage can be that an external defibrillator may be created according to embodiments that uses, in its output stage, semiconductor switches instead of relays. As semiconductor switches weigh less and occupy less volume than relays, an external defibrillator according to embodiments may have less weight and volume. Especially in wearable defibrillator applications, less weight means less effort to carry and less volume means easier concealment under clothing.Type: GrantFiled: February 28, 2022Date of Patent: October 24, 2023Assignee: West Affum Holdings DACInventors: Kenneth Frederick Cowan, Joseph Sullivan, Brian J. Bennett
-
Patent number: 11464991Abstract: In some embodiments, a wearable medical device system includes a processor configured to determine whether a patient requires electrical therapy to be provided via a plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of a stored electrical charge from an energy storage module, and if so, cause a fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two therapy electrodes and the patient's skin prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by an impedance measurement circuit, and cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.Type: GrantFiled: December 17, 2019Date of Patent: October 11, 2022Assignee: West Affum Holdings Corp.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., David Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20220266042Abstract: In embodiments, an external defibrillator has an electrical circuit with a special output stage for the high-voltage defibrillation pulse. The output stage includes switches that can turn on for delivering the pulse, and off during all other times. The output stage also includes a diverting resistance to divert electrical current that could leak into the patient while a capacitor is being charged. An optional detector may notify if a component is malfunctioning. An advantage can be that an external defibrillator may be created according to embodiments that uses, in its output stage, semiconductor switches instead of relays. As semiconductor switches weigh less and occupy less volume than relays, an external defibrillator according to embodiments may have less weight and volume. Especially in wearable defibrillator applications, less weight means less effort to carry and less volume means easier concealment under clothing.Type: ApplicationFiled: February 28, 2022Publication date: August 25, 2022Applicant: West Affum Holdings Corp.Inventors: Kenneth Frederick Cowan, Joseph Sullivan, Brian J. Bennett
-
Patent number: 11260237Abstract: In embodiments, an external defibrillator has an electrical circuit with a special output stage for the high-voltage defibrillation pulse. The output stage includes switches that can turn on for delivering the pulse, and off during all other times. The output stage also includes a diverting resistance to divert electrical current that could leak into the patient while a capacitor is being charged. An optional detector may notify if a component is malfunctioning. An advantage can be that an external defibrillator may be created according to embodiments that uses, in its output stage, semiconductor switches instead of relays. As semiconductor switches weigh less and occupy less volume than relays, an external defibrillator according to embodiments may have less weight and volume. Especially in wearable defibrillator applications, less weight means less effort to carry and less volume means easier concealment under clothing.Type: GrantFiled: November 6, 2018Date of Patent: March 1, 2022Assignee: West Affum Holdings Corp.Inventors: Kenneth Frederick Cowan, Joseph Sullivan, Brian J. Bennett
-
Publication number: 20210322759Abstract: A wearable cardioverter defibrillator (“WCD”) system may include an impedance detector configured to render an impedance signal of the patient. The WCD system may determine, from the impedance signal, a characteristic of breathing by the patient that can be used as a vital sign. The WCD system may determine, from at least the breathing characteristic, whether or not a shock criterion is met. If the shock criterion is met, the WCD system may control a discharge circuit to discharge a stored electrical charge through the patient. An advantage can be that the breathing characteristic may be used to determine whether or not a patient is experiencing a condition that requires defibrillation therapy, such as sudden cardiac arrest. Even more advantages can be had in discerning the state of the patient when the breathing characteristic is combined with other data, such as from a motion detector.Type: ApplicationFiled: June 30, 2021Publication date: October 21, 2021Applicant: West Affum Holdings Corp.Inventors: Laura M. Gustavson, Kenneth Frederick Cowan
-
Patent number: 11052241Abstract: A wearable cardioverter defibrillator (“WCD”) system may include an impedance detector configured to render an impedance signal of the patient. The WCD system may determine, from the impedance signal, a characteristic of breathing by the patient that can be used as a vital sign. The WCD system may determine, from at least the breathing characteristic, whether or not a shock criterion is met. If the shock criterion is met, the WCD system may control a discharge circuit to discharge a stored electrical charge through the patient. An advantage can be that the breathing characteristic may be used to determine whether or not a patient is experiencing a condition that requires defibrillation therapy, such as sudden cardiac arrest. Even more advantages can be had in discerning the state of the patient when the breathing characteristic is combined with other data, such as from a motion detector.Type: GrantFiled: October 25, 2017Date of Patent: July 6, 2021Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Laura M. Gustavson, Kenneth Frederick Cowan
-
Patent number: 11026578Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: GrantFiled: June 8, 2018Date of Patent: June 8, 2021Assignee: West Affum Holdings Corp.Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Patent number: 11000692Abstract: Embodiments are directed to wearable cardioverter defibrillator (WCD) systems that include patient parameter electrodes, such as ECG electrodes, that are at least substantially electrically isolated from other circuits of the WCD system. In embodiments, the WCD system includes a power source, an energy storage module, and a processor each connected to a first circuit ground. A patient parameter sense port, such as an ECG port, is coupled to the patient. A measurement circuit may render a physiological input from the sensed patient parameter received at the patient parameter sense port, and the measurement circuit includes an isolating circuit that electrically isolates the patient parameter sense port from the first circuit ground. The sensing of physiological inputs of the patient can be improved, resulting in fewer erroneous readings and false alarms.Type: GrantFiled: June 16, 2019Date of Patent: May 11, 2021Assignee: West Affum Holdings Corp.Inventors: Douglas Keith Medema, Kenneth Frederick Cowan, Zhong Qun Lu
-
Publication number: 20200121938Abstract: In some embodiments, a wearable medical device system includes a processor configured to determine whether a patient requires electrical therapy to be provided via a plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of a stored electrical charge from an energy storage module, and if so, cause a fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two therapy electrodes and the patient's skin prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by an impedance measurement circuit, and cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.Type: ApplicationFiled: December 17, 2019Publication date: April 23, 2020Applicant: West Affum Holdings Corp.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, JR., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Patent number: 10507331Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: GrantFiled: January 9, 2018Date of Patent: December 17, 2019Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20190366111Abstract: Embodiments are directed to wearable cardioverter defibrillator (WCD) systems that include patient parameter electrodes, such as ECG electrodes, that are at least substantially electrically isolated from other circuits of the WCD system. In embodiments, the WCD system includes a power source, an energy storage module, and a processor each connected to a first circuit ground. A patient parameter sense port, such as an ECG port, is coupled to the patient. A measurement circuit may render a physiological input from the sensed patient parameter received at the patient parameter sense port, and the measurement circuit includes an isolating circuit that electrically isolates the patient parameter sense port from the first circuit ground. The sensing of physiological inputs of the patient can be improved, resulting in fewer erroneous readings and false alarms.Type: ApplicationFiled: June 16, 2019Publication date: December 5, 2019Inventors: Douglas Keith Medema, Kenneth Frederick Cowan, Zhong Qun Lu
-
Patent number: 10322291Abstract: Embodiments are directed to wearable cardioverter defibrillator (WCD) systems that include patient parameter electrodes, such as ECG electrodes, that are at least substantially electrically isolated from other circuits of the WCD system. In embodiments, the WCD system includes a power source, an energy storage module, and a processor each connected to a first circuit ground. A patient parameter sense port, such as an ECG port, is coupled to the patient. A measurement circuit may render a physiological input from the sensed patient parameter received at the patient parameter sense port, and the measurement circuit includes an isolating circuit that electrically isolates the patient parameter sense port from the first circuit ground. The sensing of physiological inputs of the patient can be improved, resulting in fewer erroneous readings and false alarms.Type: GrantFiled: November 30, 2016Date of Patent: June 18, 2019Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Douglas Keith Medema, Kenneth Frederick Cowan, Zhong Qun Lu
-
Publication number: 20180289275Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: ApplicationFiled: June 8, 2018Publication date: October 11, 2018Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Patent number: 10022062Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: GrantFiled: February 14, 2017Date of Patent: July 17, 2018Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Patent number: 9987496Abstract: A wearable medical device includes a garment and a medical device. The medical device has a functionality that can transition between an operative state and an inoperative state. When the functionality is in the inoperative state, a protrusion extends so as to poke the patient, as an indication that steps need to be taken to make the device ready for use.Type: GrantFiled: August 8, 2017Date of Patent: June 5, 2018Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Joseph Leo Sullivan, Isabelle Banville, Blaine Krusor, Daniel Ralph Piha, Laura Marie Gustavson, David Peter Finch, Kenneth Frederick Cowan, Richard C. Nova
-
Publication number: 20180147414Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: ApplicationFiled: January 9, 2018Publication date: May 31, 2018Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, JR., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20180117299Abstract: A wearable cardioverter defibrillator (“WCD”) system may include an impedance detector configured to render an impedance signal of the patient. The WCD system may determine, from the impedance signal, a characteristic of breathing by the patient that can be used as a vital sign. The WCD system may determine, from at least the breathing characteristic, whether or not a shock criterion is met. If the shock criterion is met, the WCD system may control a discharge circuit to discharge a stored electrical charge through the patient. An advantage can be that the breathing characteristic may be used to determine whether or not a patient is experiencing a condition that requires defibrillation therapy, such as sudden cardiac arrest. Even more advantages can be had in discerning the state of the patient when the breathing characteristic is combined with other data, such as from a motion detector.Type: ApplicationFiled: October 25, 2017Publication date: May 3, 2018Inventors: Laura M. Gustavson, Kenneth Frederick Cowan
-
Patent number: 9895548Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: GrantFiled: June 6, 2017Date of Patent: February 20, 2018Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20170368361Abstract: A wearable medical device includes a garment and a medical device. The medical device has a functionality that can transition between an operative state and an inoperative state. When the functionality is in the inoperative state, a protrusion extends so as to poke the patient, as an indication that steps need to be taken to make the device ready for use.Type: ApplicationFiled: August 8, 2017Publication date: December 28, 2017Inventors: Joseph Leo Sullivan, Isabelle Banville, Blaine Krusor, Daniel Ralph Piha, Laura Marie Gustavson, David Peter Finch, Kenneth Frederick Cowan, Richard C. Nova